UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A new prognostic model including immune biomarkers, genomic proliferation tumor markers ( AURKA and MYBL2 ) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients

Frontiers in oncology, 2023-05, Vol.13, p.1182725-1182725

2023

Volltextzugriff (PDF)

Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study)

Breast cancer research and treatment, 2020-11, Vol.184 (2), p.469-479

2020

Volltextzugriff (PDF)

Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer

Cancers, 2023-05, Vol.15 (10), p.2846

2023

Volltextzugriff (PDF)

Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study)

Cancer treatment and research communications, 2023, Vol.37, p.100772-100772, Article 100772

2023

Volltextzugriff (PDF)

Microvesículas en cáncer de mama

Revista de senología y patología mamaria, 2016-07, Vol.29 (3), p.125-131

2016

Volltextzugriff (PDF)

High-risk of recurrence for nodal micrometastasis with breast pathologic complete response (ypT0/Tis ypN1mi) after neoadjuvant chemotherapy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e12524-e12524

2020

Volltextzugriff (PDF)

38th Annual San Antonio Breast Cancer Symposium. Resumen de las aportaciones más relevantes

Revista de senología y patología mamaria, 2016-04, Vol.29 (2), p.75-82

2016

Volltextzugriff (PDF)

413 Prognostic value of the tumor infiltrating lymphocytes and the neutrophil-to-lymphocyte ratio in patients with advanced ovarian cancer

International journal of gynecological cancer, 2020-12, Vol.30 (Suppl 4), p.A78-A79

2020

Volltextzugriff (PDF)

Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables

Scientific reports, 2019-11, Vol.9 (1), p.16979-9, Article 16979

2019

Volltextzugriff (PDF)

Abstract P4-07-11: Prognostic significance of changes in tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio after neoadjuvant chemotherapy in early breast cancer patients

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P4-P4-07-11

2022

Volltextzugriff (PDF)

Abstract P4-07-03: Development of prognostic models based on clinical, immune-related and proliferation factors in early breast cancer patients treated with neoadjuvant chemotherapy

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P4-P4-07-03

2022

Volltextzugriff (PDF)

Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes

Breast cancer research and treatment, 2024-06, Vol.205 (3), p.475-485

2024

Volltextzugriff (PDF)

Clinical meaning of stromal tumor infiltrating lymphocytes (sTIL) in luminal early breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.572-572

2023

Volltextzugriff (PDF)

Correlation of neutrophil-to-lymphocyte ratio and stromal tumor infiltrating lymphocytes across early breast cancer subtypes

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e12558-e12558

2023

Volltextzugriff (PDF)

Combined effect of obesity and comorbidity on toxicity of adjuvant chemotherapy for breast cancer (BC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1036-1036

2016

Volltextzugriff (PDF)

Metastatic breast cancer (MBC) patients′ perspective in the valuation of health states for QALY calculation

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e18131-e18131

2016

Volltextzugriff (PDF)

Abstract PS6-54: Prognostic significance of residual micrometastatic axillary involvement with complete pathologic breast response after neoadjuvant chemotherapy for early breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS6-54-PS6-54

2021

Volltextzugriff (PDF)

Abstract PS6-45: Prognostic significance of tumor-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in patients with breast cancer receivingneoadjuvant chemotherapy

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS6-45-PS6-45

2021

Volltextzugriff (PDF)

Circulating miR-200c-3p as a marker of metastatic disease at diagnosis in breast cancer patients

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12559-e12559

2017

Volltextzugriff (PDF)

Group motivational intervention in overweight/obese patients in primary prevention of cardiovascular disease in the primary healthcare area

BMC family practice, 2010-03, Vol.11 (1), p.23, Article 23

2010

Volltextzugriff (PDF)

Influence of clinical and psychological variables on coping strategies and quality of life of cancer patients: NEOCOPING study

Journal of clinical oncology, 2016-01, Vol.34 (3_suppl), p.205-205

2016

Volltextzugriff (PDF)

Circulating endothelial microparticles (EMP) modifications as predictive biomarkers of resistance to chemotherapy for breast cancer (BC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3042-3042

2013

Volltextzugriff (PDF)

Whole-exome sequencing in tumor samples from sequenom-wild-type, ALK negative stage IV lung adenocarcinoma (ADC) patients (p)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8070-8070

2013

Volltextzugriff (PDF)

Delayed recovery and increased severity of Paclitaxel-induced peripheral neuropathy in patients with diabetes

Journal of the National Comprehensive Cancer Network, 2015-04, Vol.13 (4), p.417-423

2015

Volltextzugriff (PDF)

Evaluation of the prognostic value and phenotypic determinants of Bcl-2 expression in breast invasive carcinoma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e11024-e11024

2012

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(24)
Science & Technology
(24)
Life Sciences & Biomedicine
(22)
Female
(17)
Middle Aged
(14)
Male
(13)
Adult
(12)
Aged
(11)
Risk Factors
(10)
Glomerular Filtration Rate
(9)
Albuminuria
(8)
Chronic Kidney Disease
(8)
Proteinuria
(8)
Cardiovascular System & Cardiology
(7)
Chronic Kidney Disease Detection
(6)
Chronic Kidney Disease Stages
(6)
Cociente Albúmina/creatinina En Orina
(6)
Consenso
(6)
Consensus Document
(6)
Enfermedad Renal Crónica
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A new prognostic model including immune biomarkers, genomic proliferation tumor markers ( AURKA and MYBL2 ) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients

Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study)

Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer

Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study)

Microvesículas en cáncer de mama

High-risk of recurrence for nodal micrometastasis with breast pathologic complete response (ypT0/Tis ypN1mi) after neoadjuvant chemotherapy

38th Annual San Antonio Breast Cancer Symposium. Resumen de las aportaciones más relevantes

413 Prognostic value of the tumor infiltrating lymphocytes and the neutrophil-to-lymphocyte ratio in patients with advanced ovarian cancer

Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables

Abstract P4-07-11: Prognostic significance of changes in tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio after neoadjuvant chemotherapy in early breast cancer patients

Abstract P4-07-03: Development of prognostic models based on clinical, immune-related and proliferation factors in early breast cancer patients treated with neoadjuvant chemotherapy

Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes

Clinical meaning of stromal tumor infiltrating lymphocytes (sTIL) in luminal early breast cancer

Correlation of neutrophil-to-lymphocyte ratio and stromal tumor infiltrating lymphocytes across early breast cancer subtypes

Combined effect of obesity and comorbidity on toxicity of adjuvant chemotherapy for breast cancer (BC)

Metastatic breast cancer (MBC) patients′ perspective in the valuation of health states for QALY calculation

Abstract PS6-54: Prognostic significance of residual micrometastatic axillary involvement with complete pathologic breast response after neoadjuvant chemotherapy for early breast cancer

Abstract PS6-45: Prognostic significance of tumor-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in patients with breast cancer receivingneoadjuvant chemotherapy

Circulating miR-200c-3p as a marker of metastatic disease at diagnosis in breast cancer patients

Group motivational intervention in overweight/obese patients in primary prevention of cardiovascular disease in the primary healthcare area

Influence of clinical and psychological variables on coping strategies and quality of life of cancer patients: NEOCOPING study

Circulating endothelial microparticles (EMP) modifications as predictive biomarkers of resistance to chemotherapy for breast cancer (BC)

Whole-exome sequencing in tumor samples from sequenom-wild-type, ALK negative stage IV lung adenocarcinoma (ADC) patients (p)

Delayed recovery and increased severity of Paclitaxel-induced peripheral neuropathy in patients with diabetes

Evaluation of the prognostic value and phenotypic determinants of Bcl-2 expression in breast invasive carcinoma

Suchergebnisse filtern